Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100110635> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W3100110635 endingPage "e615" @default.
- W3100110635 startingPage "e611" @default.
- W3100110635 abstract "Infliximab (IFX) has been shown to be effective rescue therapy for hospitalized ulcerative colitis patients failing intravenous (IV) corticosteroids (CS). There is little evidence, however, describing its use in similar hospitalized Crohn's Disease (CD) patients.To determine if IFX is an effective rescue therapy for IV CS resistant CD patients.A retrospective study of inpatients with CD who received IFX as rescue therapy at 2 tertiary care hospitals from January 1, 2006, to December 31, 2016. Records were reviewed for demographics, disease activity, preadmission and inpatient treatment, surgical rates, and 30- and 90-day readmission rates. Measures and Outcomes: Efficacy of IFX as rescue therapy was defined by discharge without surgery and readmission rates. Only patients failing IV CS before IFX were included in the final analysis.Forty patients received IFX, of which 17 had failed IV CS. Four patients were receiving outpatient IFX therapy, but still received IV CS during hospitalization before IFX. The mean duration of IV CS therapy before IFX was 6.9 days. Of the 15 patients (88%) who responded to rescue IFX, the median hospital stay following IFX was 3 days (range 3-18 days). Readmission rates were 29% and 47% at 30 and 90 days respectively, without further surgeries noted.In our series of hospitalized CD patients failing IV CS, those treated with IFX had low rates of urgent surgery and a generally rapid response to treatment, supporting IFX as an effective rescue therapy. By only including those with prior failure of IV CS, we have likely excluded patients for whom IFX was given in the hospital for reasons other than severe disease. Our results suggest that individuals with severe acute CD flare can be treated with early introduction of IFX, avoiding prolonged CS use, and hospitalization." @default.
- W3100110635 created "2020-11-23" @default.
- W3100110635 creator A5018876003 @default.
- W3100110635 creator A5061120163 @default.
- W3100110635 creator A5091138922 @default.
- W3100110635 date "2022-09-30" @default.
- W3100110635 modified "2023-09-26" @default.
- W3100110635 title "Infliximab as Rescue Therapy for Hospitalized Patients With Crohn's Disease Failing Intravenous Corticosteroids" @default.
- W3100110635 cites W1987925515 @default.
- W3100110635 cites W2026116536 @default.
- W3100110635 cites W2027117135 @default.
- W3100110635 cites W2048323123 @default.
- W3100110635 cites W2054468565 @default.
- W3100110635 cites W2071644653 @default.
- W3100110635 cites W2071662837 @default.
- W3100110635 cites W2086800291 @default.
- W3100110635 cites W2102013054 @default.
- W3100110635 cites W2112768046 @default.
- W3100110635 cites W2138656660 @default.
- W3100110635 cites W2171341132 @default.
- W3100110635 cites W2770769025 @default.
- W3100110635 cites W2919081348 @default.
- W3100110635 cites W2976362764 @default.
- W3100110635 cites W3149527659 @default.
- W3100110635 doi "https://doi.org/10.1097/mjt.0000000000001280" @default.
- W3100110635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33201000" @default.
- W3100110635 hasPublicationYear "2022" @default.
- W3100110635 type Work @default.
- W3100110635 sameAs 3100110635 @default.
- W3100110635 citedByCount "0" @default.
- W3100110635 crossrefType "journal-article" @default.
- W3100110635 hasAuthorship W3100110635A5018876003 @default.
- W3100110635 hasAuthorship W3100110635A5061120163 @default.
- W3100110635 hasAuthorship W3100110635A5091138922 @default.
- W3100110635 hasConcept C126322002 @default.
- W3100110635 hasConcept C141071460 @default.
- W3100110635 hasConcept C144024400 @default.
- W3100110635 hasConcept C149923435 @default.
- W3100110635 hasConcept C167135981 @default.
- W3100110635 hasConcept C2776485726 @default.
- W3100110635 hasConcept C2776694085 @default.
- W3100110635 hasConcept C2777138892 @default.
- W3100110635 hasConcept C2779134260 @default.
- W3100110635 hasConcept C2780084366 @default.
- W3100110635 hasConcept C2780479503 @default.
- W3100110635 hasConcept C2780775027 @default.
- W3100110635 hasConcept C71924100 @default.
- W3100110635 hasConceptScore W3100110635C126322002 @default.
- W3100110635 hasConceptScore W3100110635C141071460 @default.
- W3100110635 hasConceptScore W3100110635C144024400 @default.
- W3100110635 hasConceptScore W3100110635C149923435 @default.
- W3100110635 hasConceptScore W3100110635C167135981 @default.
- W3100110635 hasConceptScore W3100110635C2776485726 @default.
- W3100110635 hasConceptScore W3100110635C2776694085 @default.
- W3100110635 hasConceptScore W3100110635C2777138892 @default.
- W3100110635 hasConceptScore W3100110635C2779134260 @default.
- W3100110635 hasConceptScore W3100110635C2780084366 @default.
- W3100110635 hasConceptScore W3100110635C2780479503 @default.
- W3100110635 hasConceptScore W3100110635C2780775027 @default.
- W3100110635 hasConceptScore W3100110635C71924100 @default.
- W3100110635 hasIssue "6" @default.
- W3100110635 hasLocation W31001106351 @default.
- W3100110635 hasLocation W31001106352 @default.
- W3100110635 hasOpenAccess W3100110635 @default.
- W3100110635 hasPrimaryLocation W31001106351 @default.
- W3100110635 hasRelatedWork W1192818155 @default.
- W3100110635 hasRelatedWork W1567406491 @default.
- W3100110635 hasRelatedWork W2022030441 @default.
- W3100110635 hasRelatedWork W2101286087 @default.
- W3100110635 hasRelatedWork W2121260893 @default.
- W3100110635 hasRelatedWork W2137622052 @default.
- W3100110635 hasRelatedWork W2316770868 @default.
- W3100110635 hasRelatedWork W2326297611 @default.
- W3100110635 hasRelatedWork W4206728214 @default.
- W3100110635 hasRelatedWork W2168717165 @default.
- W3100110635 hasVolume "29" @default.
- W3100110635 isParatext "false" @default.
- W3100110635 isRetracted "false" @default.
- W3100110635 magId "3100110635" @default.
- W3100110635 workType "article" @default.